Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT03382899

Public ClinicalTrials.gov record NCT03382899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of pegilodecakin in combination with pembrolizumab versus pembrolizumab alone in participants with metastatic non-small cell lung cancer as measured by objective response rate.

Study identification

NCT ID
NCT03382899
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 19, 2018 (Actual)
Primary completion
Dec 6, 2019 (Actual)
Completion
Mar 5, 2020 (Actual)
Last update posted
Jan 20, 2021

2018 – 2020

United States locations

U.S. sites
74
U.S. states
32
U.S. cities
69
Facility City State ZIP Site status
CCI - Clearview Cancer Institute Huntsville Alabama 35805 —
Arizona Oncology Associates, P.C. Tempe Arizona 85284 —
Beverly Hills Cancer Center Beverly Hills California 90211 —
St. Joseph Heritage Medical Group Fullerton California 92835 —
Glendale Adventist Medical Center Los Angeles California 90017 —
Redlands Community Hospital Redlands California 92373 —
Redwood Regional Oncology Center Santa Rosa California 95403 —
The Oncology Institute of Hope and Innovation Whittier California 90602 —
Memorial Hospital Colorado Springs Colorado 80909 —
Kaiser Permanente Oncology Clinic Denver Colorado 80205 —
Rocky Mountain Cancer Center Lone Tree Colorado 80124 —
Veterans Affairs Connecticut Healthcare System West Haven Connecticut 06516-2770 —
Medical Oncology Hematolgy Consultants, PA Newark Delaware 19713 —
Lynn Cancer Institute Ctr for Hem-Onc Boca Raton Florida 33486 —
Memorial Cancer Institute Pembroke Pines Florida 33028 —
SCRI- Florida Cancer Specialists Tallahassee Florida 32308 —
Tallahassee Memorial Cancer Center Tallahassee Florida 32308 —
Florida Cancer Specialists East West Palm Beach Florida 33401 —
Northeast Georgia Cancer Care, LLC Athens Georgia 30607 —
Pacific Diabetes & Endocrine Center Honolulu Hawaii 96813 —
AMITA Health Cancer Institute & Outpatient Center Hinsdale Illinois 60521 —
Orchard Healthcare Research Inc Skokie Illinois 60077 —
Goshen Health System Goshen Indiana 46526 —
University of Iowa Iowa City Iowa 52242-1009 —
Covenant Clinic Waterloo Iowa 50702 —
Menorah Medical Center Overland Park Kansas 66209 —
Baptist Health Medical Group Lexington Kentucky 40503 —
Norton Cancer Institute Louisville Kentucky 40202 —
MedStar Research Institute Baltimore Maryland 21237 —
Maryland Oncology Hematology, P.A. Columbia Maryland 21044 —
Frederick Memorial Hospital Frederick Maryland 21701 —
St. Joseph Mercy Hospital Ann Arbor Michigan 48106 —
Henry Ford Hospital Detroit Detroit Michigan 48202 —
Sparrow Health System Lansing Michigan 48912 —
Minnesota Oncology/Hematology PA Minneapolis Minnesota 55404 —
University of Minnesota Hospital Minneapolis Minnesota 55455 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
St John's Mercy Medical Center St Louis Missouri 63141 —
Nebraska Hematology-Oncology Lincoln Nebraska 68506 —
Morristown Medical Center Morristown New Jersey 07962 —
The Valley Hospital - Luckow Pavilion Westwood New Jersey 07675 —
Clinical Research Alliance, Inc. Lake Success New York 11042 —
Winthrop University Hospital Mineola New York 11501 —
Stony Brook University Medical Center Stony Brook New York 11794 —
DJL Clinical Research, PLLC Charlotte North Carolina 28207 —
Southeastern Medical Oncology Center Jacksonville North Carolina 28546 —
Gabrail Cancer Center Canton Ohio 44718 —
Christ Hospital Cincinnati Ohio 45219 —
University of Toledo Medical Center Toledo Ohio 43614-2598 —
The Toledo Clinic Toledo Ohio 43623 —
Oncology Associates of Oregon Eugene Oregon 97401 —
Charleston Hematology Oncology Associates Charleston South Carolina 29414 —
Avera Cancer Institute Sioux Falls South Dakota 57105 —
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404 —
Thompson Cancer Survival Center Knoxville Tennessee 37916 —
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203 —
Texas Cancer Center (Abilene) Abilene Texas 79606 —
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702 —
Texas Oncology - Dallas Presbyterian Hospital Dallas Texas 75231 —
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology-Memorial City Houston Texas 77024 —
Millennium Oncology Houston Texas 77090 —
Joe Arrington Cancer Center Lubbock Texas 79410 —
Texas Oncology - Midland Allison Cancer Center Midland Texas 79701 —
Texas Oncology-Sherman Sherman Texas 75090-0504 —
US Oncology The Woodlands Texas 77380 —
Texas Oncology - Tyler Tyler Texas 75702 —
Texas Oncology-Deke Slayton Cancer Center Webster Texas 77598-4219 —
Texas Oncology-Wichital Falls Texoma Cancer Center Wichita Falls Texas 76310 —
Fairfax Northern Virginia Hematology Oncology, PC Fairfax Virginia 22031 —
Oncology and Hematology Associates of Southwest Virginia Inc Roanoke Virginia 24014 —
Shenandoah Oncology, P.C. Winchester Virginia 22601 —
MultiCare Regional Cancer Center - Auburn Tacoma Washington 98002 —
The Richland Hospital Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03382899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 20, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03382899 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →